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ABSTRACT
It is well established that glycosaminoglycans (GAGs) function as attachment factors for human metapneumovirus
(HMPV), concentrating virions at the cell surface to promote interaction with other receptors for virus entry and infec-
tion. There is increasing evidence to suggest that multiple receptors may exhibit the capacity to promote infectious entry
of HMPV into host cells; however, definitive identification of specific transmembrane receptors for HMPV attachment and
entry is complicated by the widespread expression of cell surface GAGs. pgsA745 Chinese hamster ovary (CHO) cells are
deficient in the expression of cell surface GAGs and resistant to HMPV infection. Here, we demonstrate that the expression
of the Ca2-dependent C-type lectin receptor (CLR) DC-SIGN (CD209L) or L-SIGN (CD209L) rendered pgsA745 cells per-
missive to HMPV infection. Unlike infection of parental CHO cells, HMPV infection of pgsA745 cells expressing DC-SIGN
or L-SIGN was dynamin dependent and inhibited by mannan but not by pretreatment with bacterial heparinase. Parental
CHO cells expressing DC-SIGN/L-SIGN also showed enhanced susceptibility to dynamin-dependent HMPV infection, con-
firming that CLRs can promote HMPV infection in the presence or absence of GAGs. Comparison of pgsA745 cells express-
ing wild-type and endocytosis-defective mutants of DC-SIGN/L-SIGN indicated that the endocytic function of CLRs was
not essential but could contribute to HMPV infection of GAG-deficient cells. Together, these studies confirm a role for
CLRs as attachment factors and entry receptors for HMPV infection. Moreover, they define an experimental system that
can be exploited to identify transmembrane receptors and entry pathways where permissivity to HMPV infection can be
rescued following the expression of a single cell surface receptor.
IMPORTANCE
On the surface of CHO cells, glycosaminoglycans (GAGs) function as the major attachment factor for human metapneu-
moviruses (HMPV), promoting dynamin-independent infection. Consistent with this, GAG-deficient pgaA745 CHO cells
are resistant to HMPV. However, expression of DC-SIGN or L-SIGN rendered pgsA745 cells permissive to dynamin-depen-
dent infection by HMPV, although the endocytic function of DC-SIGN/L-SIGN was not essential for, but could contribute
to, enhanced infection. These studies provide direct evidence implicating DC-SIGN/L-SIGN as an alternate attachment
factor for HMPV attachment, promoting dynamin-dependent infection via other unknown receptors in the absence of
GAGs. Moreover, we describe a unique experimental system for the assessment of putative attachment and entry receptors
for HMPV.
Human metapneumovirus (HMPV) can cause both upper andlower respiratory tract infections and is most commonly as-
sociated with disease in infants and young children but also in
elderly and immunocompromised patients (reviewed in reference
1). HMPV is a member of the genus Metapneumovirus within the
family Paramyxoviridae and shares structural, epidemiological,
and clinical features with respiratory syncytial virus (RSV), a
closely related paramyxovirus.
Airway epithelial cells are the predominant target of HMPV
infection (2, 3); however, infection of airway macrophages may
contribute to virus propagation during the early phase of HMPV
infection (4). HMPV also infects dendritic cells (DCs), and this
may play a role in immune evasion by interfering with the func-
tion of DCs, including their ability to activate CD4 T cells (5–8).
HMPV expresses 3 envelope glycoproteins, the putative attach-
ment (G) protein, the F protein, and the small hydrophobic (SH)
protein. For cellular infection to occur, HMPV must first attach to
the cell surface and then fuse the viral and cellular membranes, a
process that is driven by the F protein (reviewed in reference 9). To
date, there is no evidence of a role for the SH protein in viral entry,
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and mutants lacking a functional SH protein replicate efficiently
in vitro and in vivo (10, 11). Of interest, deletion mutants of
HMPV that do not express the G protein also replicate efficiently
in cell culture (11), suggesting that the F protein of HMPV can
perform both attachment and fusion functions in the absence of
the G protein. However, while HMPV lacking the G protein could
infect African green monkeys, replication was attenuated com-
pared to the wild-type virus, indicating that the G protein is re-
quired for full virulence in vivo (12). Thus, the G protein of HMPV
might bind to cellular receptors expressed by only certain cell
types, or it may mediate an entirely different function in the virus
life cycle.
Recent studies suggest that HMPV can interact with multiple
binding partners to facilitate virus attachment and subsequent
entry into target cells. An integrin binding recognition sequence,
Arg-Gly-Asp (RGD), has been identified in the F proteins of all
known HMPV strains (13), and the HMPV F protein is capable of
interacting with multiple RGD binding integrins (13–16). While
not essential for virus attachment, interactions between the F pro-
tein and integrins are required to promote efficient HMPV entry
and infection, at least for certain cell types (13, 14, 16). Of interest,
Chang et al. reported that efficient HMPV infection of Vero and
CHO-K1 cells depends on the expression of a proteinaceous re-
ceptor (17), which, in contrast to integrins, is sensitive to trypsin
and proteinase K digestion (17, 18). Thus, HMPV entry and in-
fection are likely to involve more than one cell surface receptor,
and these receptors may be distinct for different cell types. More-
over, receptors utilized by HMPV to infect epithelial cells may
differ from those involved in infectious entry into immune cells
such as macrophages and DCs.
Glycosaminoglycans (GAGs) are long, unbranched polysac-
charides that consist of repeating disaccharide subunits, of which
heparan sulfate (HS) and, to a lesser extent, chondroitin sulfate
(CS) can act as attachment factors for a range of human viruses
(reviewed in reference 19). A number of studies have shown that
HMPV infection can be inhibited in the presence of soluble GAGs
by the enzymatic removal of GAGs from the cell surface or by the
use of GAG-deficient cell lines (17, 20–22). For example, the G
protein of certain lineages of HMPV can interact with GAGs (20,
21), and this has been proposed to modulate HMPV infection.
However, Chang et al. reported that the initial interactions be-
tween HMPV and target cells occurred via the recognition of HS
moieties on the cell surface by the F protein of HMPV (17). In the
absence of HS, HMPV binding to and infection of CHO cells,
CHO cell mutants, and Vero cells were drastically reduced, indi-
cating that integrins (and/or other cell surface receptors) do not
function efficiently to promote attachment and entry in the ab-
sence of cell surface GAGs (17). Thus, GAGs appear to be the first
cell surface receptors engaged by HMPV. However, the specific
receptors and mechanisms required to trigger subsequent fusion
and cell entry are yet to be fully elucidated. HMPV entry may not
be limited to fusion at the plasma membrane, as a growing body of
evidence indicates that infectious entry can also occur following
virus internalization via endocytosis and fusion with endosomal
membranes (15, 23).
CHO pgsA745 cells represent a mutant of the CHO cell line
lacking xylosyltransferase activity and are therefore deficient in
the expression of cell surface GAGs (24). Moreover, multiple stud-
ies have demonstrated that GAG-deficient pgsA745 cells do not
bind HMPV efficiently and are resistant to HMPV infection (17,
20, 21). Therefore, we hypothesized that putative receptors could
be expressed in pgsA745 cells to assess their ability to function as
attachment and/or entry receptors for HMPV in the absence of
interactions with cell surface GAGs. C-type lectin receptors
(CLRs) have been reported to bind to glycans expressed on the
surface glycoproteins of a range of different viruses. In many stud-
ies, recognition by cell surface CLR has been associated with en-
hanced susceptibility to viral infection (reviewed in reference 25).
Recently, Le Nouen et al. reported that macropinocytosis repre-
sented the predominant route for infectious entry of HMPV into
monocyte-derived dendritic cells (MDDCs) and presented data
implicating DC-SIGN-mediated endocytosis as an alternative
pathway for HMPV entry and infection (26).
Here, we have characterized interactions between HMPV and
CHO cells deficient in either GAGs (pgsA745) or sialic acid (SIA)
(Lec2), confirming that pgsA745 cells did not bind HMPV effi-
ciently and were resistant to HMPV infection. We then utilized
pgsA745 cells to develop an experimental model to assess the abil-
ity of human DC-SIGN and L-SIGN to function as attachment
and entry receptors for HMPV. Our studies demonstrate that sta-
ble transfected pgsA745 cell lines expressing either DC-SIGN or
L-SIGN were able to bind HMPV in a Ca2-dependent manner
and showed enhanced susceptibility to dynamin-dependent
HMPV infection. Moreover, DC-SIGN/L-SIGN could augment
HMPV infection when expressed by CHO-K1 cells expressing cell
surface GAGs.
MATERIALS AND METHODS
Cell lines.CHO-Pro5 cells and the SIA-deficient mutant cell line Lec2 (27,
28), derived from CHO-Pro5 cells, were obtained from the American
Type Culture Collection (ATCC), Manassas, VA, USA. CHO-K1 cells and
the GAG-deficient mutant cell line pgsA745 (24), derived from CHO-K1
cells, were obtained from Mark Hulett, Department of Biochemistry, La
Trobe University, Melbourne, Australia. All CHO cell lines were cultured
in Dulbecco’s modified Eagle’s medium–nutrient mixture Ham F-12 me-
dium (DMEM–F-12; Gibco BRL, New York, NY, USA) supplemented
with 10% (vol/vol) fetal calf serum (FCS; JRH Biosciences, KS, USA), 4
mM L-glutamine, 100 IU penicillin, 10g of streptomycin/ml, nonessen-
tial amino acids (Gibco BRL, New York, NY, USA), and 50 M -mer-
captoethanol. LLC-MK2 (ATCC CLL7.1) cells were maintained in Opti-
MEM (Gibco BRL) supplemented with 5% FCS.
Viruses.The CAN97-83 HMPV strain was propagated in LLC-MK2
cells at 32°C in the presence of 5 g/ml tosylsulfonyl phenylalanyl
chloromethyl ketone (TPCK) trypsin (Worthington Biochemical, NJ,
USA), based on methods reported previously (11). Virus was concen-
trated from cell-free supernatants by ultracentrifugation on a 30 to
60% (wt/vol) sucrose step gradient for 2 h at 26,000 rpm at 4°C by
using an SW28 rotor (Beckman Coulter, CA, USA). The virus-contain-
ing band at the 30 to 60% interface was collected and diluted, and virus
particles were pelleted by centrifugation for 90 min at 25,000 rpm by
using an SW28 rotor (Beckman Coulter). The virus pellet was resus-
pended in serum-free Opti-MEM and frozen in aliquots at 80°C
prior to use. Titers of infectious HMPV were determined by titration
on LLC-MK2 monolayers, followed by immunofluorescence staining
with a monoclonal antibody (MAb) against the HMPV N protein
(MAB80121; Merck Millipore, MA), and titers are expressed as fluo-
rescent-focus units (FFU) per milliliter. RSV strain A2 was propagated
in HEp-2 cells by standard procedures (29). Titers of infectious RSV
were determined by titration on CV-1 cells, followed by immunoflu-
orescence staining with a MAb against the RSV fusion (F) protein
(clone 133-1H; Millipore, MA, USA), and titers are expressed as FFU
per milliliter. The influenza A virus (IAV) strain used in this study was
BJx109 (H3N2), a high-yield reassortant of A/PR/8/34 (PR8) (H1N1)
C-Type Lectins as Receptors for Metapneumovirus
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and A/Beijing/353/89 (H3N2) which expresses the H3N2 surface gly-
coproteins. IAV was grown in 10-day-old embryonated eggs by using
standard procedures (30). Titers of infectious IAV were determined by
a plaque assay on Madin-Darby canine kidney (MDCK) cells and are
expressed as PFU per milliliter (30).
Generation of pgsA745 cells expressing DC-SIGN/L-SIGN or DC-
SIGN/L-SIGN with deletions in the cytoplasmic tail. Wild-type (WT)
DC-SIGN and L-SIGN pcDNA3.1/V5-His-TOPO expression vectors
were described previously (31). PCR-generated deletion (DEL) mutants
of DC-SIGN or L-SIGN lacking the last 33 or 41 amino acids of the cyto-
plasmic tail, respectively, were also inserted into pcDNA3.1/V5-His-
TOPO vectors as described previously (32). Nucleotide sequences of all
DC-SIGN/L-SIGN constructs were confirmed by sequence analysis.
pgsA745 cells were transfected with pcDNA3.1/V5-His-TOPO expres-
sion vectors containing WT or DEL DC-SIGN/L-SIGN by using FuGene 6
transfection reagent (Roche Diagnostic, Switzerland) according to the
manufacturer’s instructions. As controls, CHO-K1 and pgsA745 cells
were transfected with pcDNA3.1/V5-His-TOPO expressing cytoplasmic
hen egg ovalbumin (OVA) lacking the sequence for cell surface traffick-
ing, as described previously (31). Stable transfectants expressing wild-type
(pgs-DC-SIGN-WT and pgs-L-SIGN-WT) or deleted (pgs-DC-SIGN-
DEL and pgs-L-SIGN-DEL) forms of DC-SIGN/L-SIGN or cytoplasmic
OVA (CHO-ctrl and pgs-ctrl) were selected in the presence of 1 mg/ml
Geneticin (G418; Invitrogen). Transfected cells were screened for cell sur-
face CLR expression by using a fluorescein-conjugated cross-reactive
MAb (clone 120612; R&D Systems, Inc.) that detects both DC-SIGN and
L-SIGN, and single cells with high cell surface CLR expression levels were
isolated by using a FACSAria cell sorter (BD Biosciences) and expanded in
culture for use in experiments.
Binding of lectins and viruses to cells. To examine the binding of
lectins and viruses to the cell surface, adherent cell lines were detached
from tissue culture flasks by using 0.75 mM EDTA in phosphate-buffered
saline (PBS) (0.05 M Na2HPO4·12H2O, 0.14 M NaCl [pH 7.4]) and
washed and resuspended in binding buffer (0.05 M Tris-HCl in 0.15 M
NaCl [pH 7.4] containing 10 mM CaCl2 and 1 mg/ml of bovine serum
albumin [BSA]). All binding assays were performed at 4°C, and cells were
washed in ice-cold binding buffer between incubations. In some experi-
ments, CaCl2 was omitted from the binding buffer and replaced with 5
mM EDTA, as indicated.
Levels of cell surface SIA expression were determined by using the
plant lectin Maackia amurensis agglutinin II (MAA; EY Laboratories, CA,
USA), which binds specifically to (2,3)-linked SIA. Cells were incubated
with 5 g/ml biotinylated MAA and washed, and bound MAA was de-
tected with streptavidin conjugated to allophycocyanin (APC). Cell sur-
face GAGs were detected by using mouse anti-human HS MAb 10E4 (US
Biological, MA, USA), followed by fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse Ig (Millipore, MA). To examine HMPV
binding, cells were incubated with 5g/ml of purified HMPV, and bound
virus was detected by using a MAb specific for the F protein of HMPV
(MAB80123; Merck Millipore, MA), followed by FITC-conjugated goat
anti-mouse Ig. In some experiments, cell suspensions were pretreated for
30 min at 37°C with 200 mU/ml of broad-spectrum bacterial sialidase
from Vibrio cholerae (type III; Sigma-Aldrich, MO, USA) or with 10 U/ml
of bacterial heparinase from Flavobacterium heparinum (type I; Sigma-
Aldrich, MO, USA) prior to use in binding assays. For all assays, cell
surface binding of lectins, MAbs, and virus was then determined by using
a FACSCalibur instrument (BD Biosciences, CA, USA).
Virus infection assays. Cells were seeded into 8-well chamber slides
(LabTek; Nunc, USA) and infected with IAV, HMPV, or RSV as described
previously (25). Briefly, after culture overnight, slides with confluent
cell monolayers were washed and incubated with virus in serum-free
medium for 1 h at 37°C (to allow virus binding and entry). Unless
otherwise stated, cells were infected with 107 PFU of IAV (multiplicity
of infection [MOI]  100), 3  105 FFU of HMPV (MOI  3), and
2.5  105 FFU of RSV (MOI  2.5) in 100 l of serum-free medium.
After removal of the virus inoculum, cells were washed and incubated for
a further 6 to 8 h (for IAV) or 18 to 20 h (for HMPV/RSV) at 37°C in
serum-free medium. Slides were washed with PBS and then fixed with
80% (vol/vol) acetone. IAV-infected cells were detected by immunofluo-
rescence staining using MAb MP3.10g2.1C7 (WHO Collaborating Centre
for Reference and Research on Influenza, Melbourne, Australia) specific
for the nucleoprotein (NP) of type A influenza viruses, followed by FITC-
conjugated goat anti-mouse Ig. HMPV- and RSV-infected cells were de-
tected by using MAbs raised to the HMPV N protein (MAB80121; Merck
Millipore, MA) and the RSV F protein (clone 133-1H; Millipore, MA,
USA), respectively, followed by FITC-conjugated goat anti-mouse Ig. The
percentage of infected cells was determined by costaining with 4=,6-di-
amidino-2-phenylindole (DAPI) and counting the total number of cells
versus FITC-positive cells at a 100 magnification. A minimum of four
random fields were selected for counting, assessing at least 200 cells for
each sample. In some experiments, cell monolayers were treated with
200 mU of bacterial sialidase or 10 U/ml of bacterial heparinase I for 30
min at 37°C and washed prior to virus infection. In other experiments,
cells were pretreated with 10 mg/ml mannan (Sigma-Aldrich, MO,
USA), 50 M dynasore (Sigma-Aldrich, MO, USA), 20 mM NH4Cl, or
20 M bafilomycin A1 (Baf-A1; Sigma-Aldrich, MO, USA) in serum-
free medium for 30 min at 37°C. Cells were then infected with virus in
the presence of the appropriate inhibitor for 1 h at 37°C, washed, and
cultured for an additional 6 to 8 h (for IAV) or 18 to 20 h (for HMPV/
RSV) in the presence of the inhibitor, prior to fixing and immunoflu-
orescence staining.
Binding of recombinant human DC-SIGN/L-SIGN to HMPV by an
enzyme-linked immunosorbent assay. For enzyme-linked immunosor-
bent assays (ELISAs), 96-well polyvinyl microtiter plates were coated with
1 g/ml of purified HMPV overnight and then blocked for 2 h at room
temperature (RT) with BSA (10 mg/ml). Wells were washed with Tris-
buffered saline (TBS) containing 0.05% (vol/vol) Tween 20 (TBST) and
incubated at RT for 2 h with 1g/ml of recombinant human DC-SIGN or
L-SIGN expressing a human Fc receptor tag (DC-SIGN/L-SIGN-Fc; R&D
Systems, MN, USA) in TBS containing 5 mg/ml BSA and supplemented
with either 20 mM CaCl2 or 10 mM EDTA. Wells were washed in TBST
containing either 20 mM CaCl2 or 10 mM EDTA and then incubated
with goat anti-human IgG conjugated to horseradish peroxidase
(HRP; Millipore, MA, USA). Binding of DC-SIGN/L-SIGN-Fc to pu-
rified HMPV was detected by using 3,3=,5,5=-tetramethylbenzidine
(TMB) substrate reagent (Perkin-Elmer, CT, USA), and the reaction
was stopped with 1 M HCl.
Internalization of a DC-SIGN/L-SIGN-specific MAb by pgsA745
cells expressing WT or DEL forms of DC-SIGN/L-SIGN. Cells seeded
into duplicate 8-well chamber slides were cultured overnight, washed in
serum-free medium, and incubated with MAb (clone 120612) (cross-
reactive with DC-SIGN and L-SIGN) for 30 min at 4°C (to allow binding
to the cell surface). Cells were then washed, and one chamber slide was
moved to a temperature of 37°C for an additional 20 min (to allow MAb
internalization and entry), while the duplicate chamber slide was held at
4°C. After this time, slides were washed with PBS and fixed in 80% (vol/
vol) acetone in water. For binding and internalization of the MAb, detec-
tion of the MAb was enhanced by using Alexa Fluor 488 goat anti-mouse
Ig (Life Technologies, Eugene, OR, USA). All slides were costained with
DAPI to detect cell nuclei and examined by confocal microscopy. Images
were acquired with a Zeiss LSM700 confocal microscope in conjunction
with Zen2012 software.
Statistical analysis. Graphing and statistical analysis of data were per-
formed by using GraphPad Prism (GraphPad Software, San Diego, CA,
USA). Unpaired Student’s t test was used to compare two sets of data. For
comparison of three or more sets of values, the data were analyzed by
one-way analysis of variance (ANOVA) (nonparametric), followed by
post hoc analysis using Tukey’s multiple-comparison test. P values of
0.05 were considered significant.
Gillespie et al.
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RESULTS
Expression of SIA andGAGs by CHO-K1, pgsA745, CHO-Pro5,
and Lec2 cells. The Lec2 CHO cell line is a mutant of the CHO-
Pro5 cell line that is deficient in terminal SIA due to a defect in the
cytidine monophosphate (CMP)-SIA transporter (28, 33),
whereas the pgsA745 CHO cell line is a mutant of the CHO-K1 cell
line that lacks xylosyltransferase activity and therefore does not
express cell surface GAGs (24). Initial studies were aimed at con-
firming the phenotype of parental and mutant CHO cell lines. As
parental CHO lines (CHO-Pro5 and CHO-K1) express (2,3)-
linked but not(2,6)-linked SIA, due to a deficiency in galactoside
2,6-sialyltransferase (34, 35), we used the plant lectin MAA to
detect (2,3)-linked SIA on the surface of CHO-Pro5, Lec2,
CHO-K1, and pgsA745 cells. Representative histograms of MAA
binding are shown in Fig. 1Ai, and geometric means representing
fluorescence from triplicate samples are shown in Fig. 1Aii.
CHO-K1 and pgsA745 cells bound the highest levels of MAA, with
binding to CHO-Pro5 cells being significantly reduced compared
to binding to CHO-K1 cells in multiple experiments. MAA bind-
ing to SIA-deficient Lec2 cells was negligible and markedly re-
duced compared to binding to all other cell lines (Fig. 1A). As
expected, desialylation of cells with bacterial sialidase led to major
and significant reductions in cell surface SIA levels and therefore
in MAA binding to CHO-K1, pgsA745, and CHO-Pro5 cells (Fig.
1A). Desialylation of Lec2 cells was also associated with a modest,
but not significant, reduction in MAA binding (Fig. 1A), consis-
tent with previous studies reporting that SIA levels are drastically
reduced, but not absent, compared to those in CHO-Pro5 cells
(28, 36).
To assess cell surface expression of GAGs, cell lines were incu-
bated with a mouse MAb specific for HS (10E4 epitope), followed
by FITC-conjugated rabbit anti-mouse IgM/IgG. Representative
histograms are shown in Fig. 1Bi, and the geometric means for
triplicate samples are shown in Fig. 1Bii. As expected, HS was
expressed at high levels by CHO-K1, CHO-Pro5, and Lec2 cells
but not by pgsA745 cells. As expected, pretreatment of CHO-K1,
CHO-Pro5, and Lec2 cells with bacterial heparinase I resulted in
major reductions in cell surface expression of HS but did not alter
expression by pgsA745 cells, confirming the severe deficiency in
the cell surface expression of GAGs in these cells (24).
Ability of HMPV to bind to and infect CHO-K1, pgsA745,
CHO-Pro5, and Lec2 cells. Cell surface GAGs have been impli-
cated as the major attachment factor for HMPV (17, 20–22). To
confirm these findings and to determine the role of cell surface SIA
in HMPV attachment and entry, we examined the ability of
HMPV to bind to parental and mutant CHO cell lines. HMPV
bound efficiently to the surface of CHO-K1, CHO-Pro5, and Lec2
cells, and binding was abrogated by pretreatment of cells with
bacterial heparinase but not sialidase (Fig. 1Ci). Statistical analy-
ses confirmed that for each of these cell lines, heparinase treatment
reduced HMPV attachment significantly, whereas sialidase treat-
ment did not (Fig. 1Cii). HMPV did not bind efficiently to GAG-
deficient psgA745 cells, and pretreatment with bacterial sialidase
or heparinase did not significantly affect binding (Fig. 1Ci and ii).
In additional experiments, we confirmed that pretreatment of
CHO-K1 cells with the same concentration of sialidase reduced
the binding of purified IAV by	90% (data not shown). Thus, the
attachment of HMPV to CHO cell lines used in these studies oc-
curs primarily via the recognition of cell surface GAGs.
Next, we determined the susceptibility of CHO cell lines to
infection by HMPV. In these studies, cell monolayers were inoc-
ulated with HMPV (3 105 FFU) for 1 h at 37°C. After washing,
one set of monolayers was incubated for a further 1 h and then
fixed and stained for the expression of viral NP. Duplicate mono-
layers fixed at 18 h postinfection were also stained for viral NP and
examined by immunofluorescence microscopy. Representative
images of CHO-K1 and pgsA745 cells infected with HMPV (Fig.
1Di) are shown. Negligible HMPV staining was evident at 2 h
postinfection (Fig. 1Di, top), whereas HMPV NP localized to
punctate cytoplasmic bodies in CHO-K1 cells at 18 h (Fig. 1Di,
bottom). In contrast, few pgsA745 cells showed expression of
HMPV NP at 18 h postinfection. These studies confirmed that
susceptibility to HMPV infection, as assessed by immunofluores-
cence at 18 h, corresponds to the detection of newly synthesized
viral proteins rather than detection of residual virus inoculum.
To determine the percentage of HMPV-infected cells at 18 h
postinfection, DAPI-positive (DAPI) and fluorescent NP cells
were counted. As shown in Fig. 1Dii, CHO-K1, CHO-Pro5, and
Lec2 cells were all highly susceptible to infection by HMPV,
whereas pgsA745 cells were largely resistant. Consistent with
HMPV binding data (Fig. 1C), pretreatment of CHO-K1, CHO-
Pro5, and Lec2 cells with heparinase, but not with sialidase, abro-
gated susceptibility to HMPV infection (Fig. 1Dii). Note that pre-
treatment of CHO-K1 cells with an equivalent concentration of
sialidase reduced IAV infection from 80% to
5% when assessed
by immunofluorescence at 8 to 10 h postinfection (data not
shown). Confirming the findings reported previously by Chang et
al. (17), we report that attachment to and infection of CHO cell
lines by HMPV strain CAN97-83 are dependent on cell surface
GAGs. However, it is currently unclear if GAG-dependent bind-
ing and infection are broadly applicable to different HMPV
strains, particularly given that binding to GAGs can be acquired as
a result of adaptation to growth in tissue culture (reviewed in
reference 37). For the purposes of our study, we focus on the
expression of putative attachment and entry receptors for HMPV
in pgsA745 cells, removing the complicating factor of GAG-de-
pendent interactions that might contribute to infection.
Expression of DC-SIGN or L-SIGN by GAG-deficient
pgsA745 CHO cells is associated with Ca2-dependent binding
of HMPV. A previous study implicated DC-SIGN-mediated rec-
ognition of HMPV in entry into DCs (26), although direct binding
interactions were not investigated. We first examined the ability of
recombinant human DC-SIGN or L-SIGN to bind to HMPV by
an ELISA. In these studies, wells coated with purified HMPV
were incubated with 1 g/ml of recombinant DC-SIGN-Fc or
L-SIGN-Fc in the presence of 10 mM Ca2 or 5 mM EDTA, and
bound CLRs were detected as described in Materials and Methods.
As shown in Fig. 2A, both DC-SIGN-Fc and L-SIGN-Fc bound to
HMPV in the presence of Ca2 but not EDTA, confirming the
Ca2-dependent recognition of HMPV by both CLRs.
To examine the potential of these CLRs to act as attachment
and/or entry receptors for HMPV, we transfected pgsA745 cells
with human DC-SIGN or L-SIGN and selected clones showing
stable cell surface expression of each receptor. Flow cytometric
analyses confirmed the cell surface expression of either DC-SIGN
(Fig. 2B, left) or L-SIGN (Fig. 2B, right) on pgsA745-DC-SIGN or
pgsA745-L-SIGN cells, respectively, compared to control cells ex-
pressing intracellular OVA (pgsA745-ctrl). Stable transfectants
expressed higher cell surface levels of L-SIGN than of DC-SIGN,
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FIG 1 Attachment to and infection of CHO-K1, pgsA745, CHO-Pro5, and Lec2 cells by HMPV. (A) Binding of biotinylated MAA to SIA on CHO-K1 (K1),
pgsA745 (pgs), CHO-Pro5 (Pro5), and Lec2 cells was determined by flow cytometry. Black histograms represent cells incubated in medium alone, white
histograms represent cells incubated in medium supplemented with 100 mU/ml of bacterial sialidase, and gray histograms represent cells stained with FITC-
conjugated rabbit anti-mouse IgM/IgG alone [No MAA ()]. (i) Representative histograms of triplicate samples. (ii) MAA binding represented as the geometric
mean fluorescence intensity (1 standard error of the means) of histograms for triplicate samples. * indicates that binding to sialidase-treated cells is significantly
reduced compared to binding to mock-treated cells, and # indicates that binding to CHO-Pro5 mock cells is significantly reduced compared to binding to
CHO-K1 mock cells (P
 0.05, as determined by one-way ANOVA followed by Tukey’s post hoc test). ns, not significant. (B) Anti-HS MAb binding to GAGs on
different CHO cell lines. Cells were incubated in medium alone (black histograms) or medium supplemented with 10 U/ml of bacterial heparinase I (white
Gillespie et al.
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as detected by using a MAb that is cross-reactive with DC-SIGN
and L-SIGN.
DC-SIGN and L-SIGN contain C-type CRDs that bind to man-
nose-rich oligosaccharides in a Ca2-dependent manner. There-
fore, we assessed the ability DC-SIGN and L-SIGN expressed by
GAG-deficient pgsA745 cells to bind to HMPV in the presence of
Ca2 or EDTA. Representative histograms of HMPV binding are
shown in Fig. 2C, and the mean fluorescence from triplicate sam-
ples is shown in Fig. 2D. HMPV bound to K1-ctrl cells, but not to
GAG-deficient pgs-ctrl cells, in the presence of Ca2 or EDTA,
consistent with Ca2-independent recognition of GAGs on the
surface of K1-ctrl cells. In contrast, the expression of either DC-
SIGN or L-SIGN by pgsA745 cells was associated with enhanced
HMPV binding in the presence of Ca2, and this was abolished in
the presence of EDTA (Fig. 2C and D). Thus, DC-SIGN/L-SIGN
expressed on the surface of GAG-deficient pgsA745 cells could
mediate C-type lectin-mediated recognition of HMPV.
DC-SIGN and L-SIGN facilitate GAG-independent infection
of cells by HMPV but not by RSV. Next, we investigated the abil-
ity of DC-SIGN or L-SIGN to rescue the permissivity of pgsA745
cells to infection by HMPV. In these studies, an HMPV inoculum
was added to cells for 1 h at 37°C and removed by washing, and
histograms) and washed, and binding of anti-HS MAb was determined. Gray histograms represent cells stained with FITC-conjugated rabbit anti-mouse
IgM/IgG alone [No HS mAb ()]. (i) Representative histograms for triplicate samples. (ii) Anti-HS MAb binding represented as the geometric mean fluores-
cence intensity (1 standard error of the mean) of histograms for triplicate samples. * indicates that anti-HS MAb binding to heparinase-treated cells is
significantly different from binding to mock-treated cells (P
 0.05, as determined by one-way ANOVA followed by Tukey’s post hoc test). (C) Binding of HMPV
to CHO cell lines. Cells were incubated in serum-free medium alone (black histograms) or pretreated with either 100 mU/ml of bacterial sialidase (white
histograms) or 10 U/ml of bacterial heparinase I (light gray histograms) and then washed, and virus binding was determined. Dark gray histograms represent cells
stained with primary and secondary antibodies only (no virus). (i) Representative histograms of HMPV binding for triplicate samples. (ii) HMPV binding
represented as the geometric mean fluorescence intensity (1 standard error of the mean) of histograms for triplicate samples. * indicates that HMPV binding
to heparinase-treated cells is significantly different from binding to mock- and sialidase-treated cells (P
 0.05, as determined by one-way ANOVA followed by
Tukey’s post hoc test). (D) Infection of CHO cell lines by HMPV. Cell monolayers were incubated with 3 105 FFU (MOI of 3 FFU/cell) of HMPV for 1 h at 37°C,
washed, incubated for a further 1 h and 17 h, and then fixed and stained for the expression of newly synthesized viral N and DAPI (to stain cell nuclei for total
cell counts). (i) Representative images of HMPV-infected CHO-K1 and pgsA745 cells at 2 and 18 h were taken by confocal microscopy. (ii) The percentage of
HMPV-infected cells was determined by counting the total number of DAPI cells versus FITC cells at a100 magnification at 18 h postinfection. Data show
mean percentages of infection (1 standard error of the mean) from a minimum of four independent fields per chamber and are representative of results from
three independent experiments. * indicates results that are significantly different compared to mock- and sialidase-treated cells for HMPV.
FIG 2 Expression of DC-SIGN or L-SIGN on the surface of GAG-deficient pgsA745 CHO cells is associated with Ca2-dependent binding of HMPV. (A) ELISA
plates coated with purified HMPV were incubated with 1g/ml of recombinant DC-SIGN-Fc or L-SIGN-Fc in the presence of 10 mM Ca2or 5 mM EDTA. After
washing, levels of DC-SIGN/L-SIGN binding were determined as described in Materials and Methods. Data represent the mean optical densities (OD) from
triplicate samples (1 standard error of the mean) and are representative of results from two independent experiments. * indicates that HMPV binding was
significantly reduced in the presence of EDTA (P
 0.0001, as determined by unpaired two-tailed Student’s t test). (B) Cell surface expression of DC-SIGN or
L-SIGN on pgsA745 cells (pgs-DC/L-SIGN) or pgsA745 cells expressing an irrelevant intracellular protein (pgs-ctrl cells) was determined by flow cytometry using
a cross-reactive MAb that detects both DC-SIGN and L-SIGN. (C) Binding of HMPV to the surface of CHO-K1-ctrl (K1-ctrl), pgsA745-ctrl (pgs-ctrl),
pgs-DC-SIGN, and pgs-L-SIGN cells was determined by flow cytometry in the presence of 10 mM CaCl2 (Ca
2) or 5 mM EDTA. A sample that received no
HMPV but was stained with all relevant antibodies was included for comparison (no virus). Representative histograms for triplicate samples are shown. (D)
Geometric mean HMPV binding to cells in the presence of 10 mM CaCl2 or 5 mM EDTA (1 standard error of the mean) from histograms for triplicate samples.
Data are representative of results from three independent experiments. * indicates that HMPV binding to pgs-DC-SIGN/L-SIGN cells was significantly reduced
with EDTA compared to Ca2 (P
 0.0001, as determined by two-tailed unpaired Student’s t test).
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cells were then cultured for an additional 17 h. Infected cells were
fixed, stained for the HMPV N protein, and examined by immu-
nofluorescence. Consistent with data shown in Fig. 1D, K1-ctrl
cells were highly susceptible to HMPV infection, whereas pgs-ctrl
cells were largely resistant (Fig. 3A). Moreover, the expression of
either DC-SIGN or L-SIGN by pgsA745 cells was associated with a
significant enhancement in susceptibility to HMPV infection (Fig.
3A). These findings indicate that the poor ability of HMPV to
infect pgsA745 cells does not represent a defect in the intrinsic
ability of pgsA745 cells to support HMPV infection but rather that
pgsA745 cells lack appropriate cell surface receptors for virus at-
tachment and/or entry. Note that pgs-L-SIGN cells were more
susceptible than pgs-DC-SIGN cells to HMPV infection, consis-
tent with higher cell surface expression levels of CLRs on pgs-L-
SIGN cells (Fig. 2B). As an alternative approach, flow cytometry
confirmed that the expression of either DC-SIGN or L-SIGN by
pgsA745 cells was associated with an enhanced susceptibility to
infection (Fig. 3B). K1-ctrl, pgs-DC-SIGN, and pgs-L-SIGN cells
showed a marked enhancement of the expression of the HMPV N
protein at between 2 and 18 h postinfection, confirming that de-
tection at 18 h represents the synthesis of new viral N and there-
fore true infection by HMPV.
GAGs have been implicated as attachment factors that are es-
sential for the initiation of infection by RSV (38–40), a paramyxo-
virus closely related to HMPV. Johnson et al. reported that DC-
SIGN and L-SIGN bind to the G protein of RSV; however, stable
K562, Raji, or NIH 3T3 cell lines expressing either DC-SIGN or
L-SIGN did not show enhanced susceptibility to RSV infection
(41). We therefore examined the susceptibility GAG-deficient
pgsA745 cells expressing DC-SIGN/L-SIGN to infection by RSV.
As expected, K1-ctrl cells were susceptible to RSV, whereas GAG-
deficient pgs-ctrl cells were resistant (Fig. 3C), confirming the
importance of GAGs in mediating RSV infection of CHO cells.
Moreover, the expression of cell surface CLRs by pgs-DC-SIGN or
pgs-L-SIGN cells did not result in enhanced susceptibility to RSV
infection relative to pgs-ctrl cells (Fig. 3C). Together, these data
indicate that the expression of DC-SIGN/L-SIGN by GAG-defi-
cient pgsA745 cells can promote infectious entry of HMPV but
not RSV.
To determine if HMPV infection of pgsA745 cells expressing
DC-SIGN/L-SIGN occurred independently of residual GAGs and
involved lectin-mediated recognition of virus, cells were either (i)
treated with bacterial heparinase prior to infection or (ii) incu-
bated with mannan, a multivalent inhibitor of DC-SIGN and L-
SIGN, prior to and during infection with HMPV. For infections of
K1-ctrl cells, we included treatments at the standard inoculum
dose (high [MOI 3 FFU/cell]), resulting in80% infection, as
well as a lower inoculum dose (low [MOI 0.3 FFU/cell]), result-
ing in25% infection. We rationalized that lower levels of HMPV
infection of K1-ctrl cells would be more sensitive to the effects of
various inhibitors and treatments used in infection assays. For all
other cell lines, the standard inoculum dose was used. At both high
and low inoculum doses, HMPV infected K1-ctrl cells, and treat-
ment with bacterial heparinase reduced HMPV infection to
5%
(Fig. 3Di). However, pretreatment with heparinase had only neg-
ligible effects on HMPV infection of pgs-DC-SIGN or pgs-L-
SIGN cells, confirming the GAG-independent infection of these
cell lines (Fig. 3Dii). In the presence of mannan, HMPV infection
of K1-ctrl cells was largely unaffected (Fig. 3Ei), whereas mannan
blocked HMPV infection of both pgsA745-DC-SIGN and
pgsA745-L-SIGN cells to significant levels (Fig. 3Eii). Thus, infec-
tious entry of HMPV into CHO-K1 cells is blocked by pretreat-
ment with heparinase but is unaffected in the presence of mannan.
In contrast, HMPV infection of pgsA745 cells expressing DC-
SIGN/L-SIGN is unaffected by pretreatment with heparinase but
is blocked in the presence of mannan.
DC-SIGN/L-SIGN-mediated infection of GAG-deficient
pgsA745 cells by HMPV occurs via a dynamin-dependent, pH-
independent route. Following attachment to the cell surface, a
number of entry pathways have been implicated in HMPV infec-
tion, including direct fusion, macropinocytosis, and endocytosis
(reviewed in reference 9). Dynasore is a small-molecule inhibitor
of the GTPase dynamin 2, which is essential for endocytic vesicle
formation, as it pinches the endosome from the plasma mem-
brane to form early endosomes (42). First, we confirmed that 50
M dynasore was sufficient to inhibit IAV infection of K1-ctrl
cells, as this virus is known to infect CHO cells via dynamin-
dependent endocytosis (Fig. 4Aiii). Next, we examined the effects
of dynasore on HMPV infection of K1-ctrl cells, compared to
pgsA745 cells expressing DC-SIGN or L-SIGN. The addition of
dynasore (50 M) had no effect on HMPV infection of K1-ctrl
cells, even when a lower inoculum dose of virus was used, which
led to reduced infection levels of K1-ctrl cells (Fig. 4Ai). However,
HMPV infection of pgsA745-DC-SIGN and pgsA745-L-SIGN
cells was completely blocked in the presence of dynasore (Fig.
4Aii), indicating that CLR-mediated infection of pgsA745 cells
expressing DC-SIGN or L-SIGN occurred via dynamin-depen-
dent endocytosis. Of interest, the low levels of HMPV infection in
pgs-ctrl cells were also significantly blocked in the presence of
dynasore, suggesting that dynamin-dependent endocytosis of
HMPV might occur at low levels in this GAG-deficient cell line.
IAV enters and infects host cells in a pH-dependent manner,
and endosomal acidification is required to induce an irreversible
conformational change in viral hemagglutinin (HA), activating its
membrane fusion activity and facilitating the release of the viral
capsid into the cytoplasm (reviewed in reference 43). Consistent
with this, incubation of K1-ctrl cells with 20 mM NH4Cl, a weak
base that inhibits endosomal acidification (44), completely inhib-
ited susceptibility to IAV infection (Fig. 4Biii). While HMPV in-
fection of cells is generally considered to occur via pH-indepen-
dent pathways, some studies have indicated that fusion and/or
infectious entry of certain strains can be enhanced under acidic
conditions (23, 45, 46). More recently, Mas et al. reported that
there was no correlation between the effects of inhibitors of endo-
somal acidification on infectivity and the sensitivity of the F pro-
teins of different strains to low pH in a syncytium formation assay
(47). In our studies, while 20 mM NH4Cl completely inhibited
IAV infection of K1-ctrl cells, it had no significant effects on
HMPV infection of K1-ctrl cells (Fig. 4Bi) or pgsA745 cells ex-
pressing either DC-SIGN or L-SIGN (Fig. 4Bii). Similar results
were obtained by using 20M bafilomycin A1, an inhibitor of the
vacuolar-type H-ATPase, which also prevents endosomal acidi-
fication (48), which potently inhibited IAV infection of K1-ctrl
cells (Fig. 4Ciii) but did not alter the susceptibility of K1-ctrl (Fig.
4Ci), pgs-DC-SIGN, or pgs-L-SIGN cells to HMPV infection (Fig.
4Cii). Note that the concentrations of dynasore, NH4Cl, and ba-
filomycin A1 used did not result in the detachment of adherent
cells (as determined by counting the total number of propidium
iodide-positive [PI] cells after 18 h of incubation compared to
Gillespie et al.
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FIG 3 DC-SIGN and L-SIGN facilitate GAG-independent infection of cells by HMPV but not by RSV. (A and B) Monolayers of K1-ctrl, pgs-ctrl, pgs-DC-SIGN,
and pgs-L-SIGN cells were incubated with 3 105 FFU (MOI of 3 FFU/cell) of HMPV for 60 min at 37°C and then washed and incubated for a further 17 h. (A)
Cells were fixed and stained by immunofluorescence for the expression of newly synthesized viral N as described in Materials and Methods. Data represent the
mean percentages of HMPV-infected cells (1 standard error of the mean) from a minimum of four independent fields per chamber and are representative of
results of three independent experiments. * indicates values that are significantly increased compared to values for pgs-ctrl cells (P 
 0.05, as determined by
one-way ANOVA followed by Tukey’s post hoc test). (B) Cells were fixed, permeabilized, stained for expression of the HMPV N protein, and then examined by
flow cytometry. Histograms show the expression of the HMPV N protein 2 h and 18 h after exposure to HMPV. The percentages of HMPV-infected cells at 18
h postinfection are indicated. (C) Monolayers were infected with 3 105 FFU (MOI of 3 FFU/cell) of RSV as described above and assessed by immunofluores-
cence at 18 h postinfection. Data represent the mean percentages of RSV-infected cells (1 standard error of the mean) from a minimum of four independent
fields per chamber and are representative of results from two independent experiments. ns, not significantly different compared to pgs-ctrl cells (as determined
by one-way ANOVA followed by Tukey’s post hoc test). (D and E) Monolayers of K1-ctrl, pgs-DC-SIGN, or pgs-L-SIGN cells were incubated at 37°C for 30 min
in serum-free medium with 10 mg/ml mannan ( mannan) or without mannan (virus only) prior to the addition of HMPV (D) or pretreated with 10 U/ml
bacterial heparinase at 37°C for 30 min and washed prior to infection with HMPV (E). Note that K1-ctrl cells were inoculated with either a high dose (MOI
3 FFU/cell) or a low dose (MOI 0.3 FFU/cell) of HMPV (i), whereas all other cells were inoculated with only a high dose (ii). Cells were incubated for 1 h at
37°C after virus addition, washed, and then cultured for an additional 17 h in the presence (mannan) or absence (virus only) of 10 mg/ml mannan. After this
time, cells were fixed and stained by immunofluorescence for the presence of newly synthesized viral N. Data represent the mean percentages of infected cells (1
standard error of the mean) and are pooled from two independent experiments. * indicates that values for mannan-treated cells are significantly reduced
compared to those for untreated cells for pgs-DC-SIGN (P
 0.0001) and pgs-L-SIGN (P
 0.0001) cells, as determined by using unpaired two-tailed Student’s
t test.
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mock-treated controls), confirming that these concentrations
were not toxic (data not shown).
DC-SIGN/L-SIGN expression augments HMPV infection of
CHOcells expressing cell surfaceGAGs.GAG-deficient pgsA745
cells provide a unique experimental system to study interactions
between HMPV and putative attachment/entry receptors, in the
absence of additional interactions with cell surface GAGs. How-
ever, under physiological conditions, CLRs such as DC-SIGN and
L-SIGN will be expressed on the surface of cells that also express
GAGs. Therefore, it is important to determine if DC-SIGN/L-
SIGN augments or inhibits HMPV infection by cells expressing
cell surface GAGs. To examine this, we generated lines of parental
CHO-K1 cells expressing either DC-SIGN or L-SIGN (Fig. 5A).
Next, we infected K1-ctrl, K1-DC-SIGN, and K1-L-SIGN cells
FIG 4 DC-SIGN/L-SIGN-mediated infection of GAG-deficient pgsA745 cells by HMPV occurs via a dynamin-dependent, pH-independent route. Monolayers
of K1-ctrl, pgs-ctrl, pgs-DC-SIGN, or pgs-L-SIGN cells were treated with 50 M dynasore ( dynasore) or mock treated (virus only) (A), with 20 mM NH4Cl
(NH4Cl) or mock treated (virus only) (B), or with 20M bafilomycin ( bafilomycin) or mock treated (virus only) (C) for 30 min at 37°C and then infected
with HMPV. Note that K1-ctrl cells were inoculated with either a high dose (MOI 3 FFU/cell) or a low dose (MOI 0.3 FFU/cell) of HMPV (i), whereas all
other cells were inoculated with only a high dose (ii). Additional monolayers were inoculated with a standard dose of IAV (iii). After incubation with virus, cells
were washed, cultured in serum-free medium alone (virus only) or supplemented with either 50 M dynasore ( dynasore) or 20 mM NH4Cl ( NH4Cl) for
an additional 7 h (IAV) or 17 h (HMPV), and then fixed and stained by immunofluorescence for the expression of viral NP/N. Data represent the mean
percentages of infected cells (1 standard error of the mean) from a minimum of four independent fields per chamber and are pooled from results of two
independent experiments. In panel A, * indicates that HMPV infection is significantly different from infection of untreated cells (virus only) for pgs-ctrl (P
0.0100), pgs-DC-SIGN (P
 0.0001), and pgs-L-SIGN (P
 0.0001) cells, and # indicates that IAV infection is significantly different from infection of untreated
cells (virus only) for K1-ctrl cells (P 
 0.0001) (as determined by two-tailed unpaired Student’s t test). In panels B and C, # indicates that IAV infection is
significantly different from infection of untreated cells (virus only) for K1-ctrl cells (P
 0.0001) (as determined by two-tailed unpaired Student’s t test).
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with a low inoculum dose and determined the percentage of
HMPV-infected cells at 18 h postinfection in the presence or ab-
sence of dynasore. As shown in Fig. 5B, expression of DC-SIGN or
L-SIGN was associated with a significant enhancement of the per-
centage of HMPV-infected cells. Of interest, the enhanced levels
of HMPV infection were reduced to background levels equivalent
to those of CHO-K1-ctrl cells in the presence of dynasore. Thus, in
CHO-K1 cells expressing DC-SIGN/L-SIGN, both dynamin-in-
dependent (i.e., the typical pathway of HMPV infection of
CHO-K1 cells) and dynamin-dependent (i.e., an additional path-
way of HMPV infection introduced following the expression of
CLRs) pathways of HMPV infection occur simultaneously.
SusceptibilityofpgsA745cells expressingendocytosis-defec-
tivemutants of DC-SIGN/L-SIGN toHMPV infection. In previ-
ous studies, endocytosis-defective mutants of different CLRs were
generated via mutation or deletion of the intracellular domain
(32, 49, 50). Therefore, we generated pgsA745 cell lines expressing
DC-SIGN or L-SIGN with the entire N-terminal intracellular do-
main of DC-SIGN (33 amino acids) or L-SIGN (41 amino acids)
deleted (DEL). Flow cytometry was used to confirm cell surface
expression of DC-SIGN-DEL or L-SIGN-DEL on pgsA745 cell
lines (Fig. 6A). Note that clones of DC-SIGN/L-SIGN-DEL mu-
tants expressed higher levels of CLR than clones expressing the
relevant WT receptor.
To confirm that the deletion of the N-terminal intracellular
domain abrogated the endocytic capacity of DC-SIGN/L-SIGN,
cell monolayers were incubated with an anti-DC-SIGN/L-SIGN
MAb at 4°C to facilitate binding to cell surface CLRs and then
moved to a temperature of 37°C to promote internalization. Fol-
lowing incubation at 4°C, MAb bound to the surface of pgsA745
cells expressing WT and DEL forms of DC-SIGN (Fig. 6B, left).
However, when moved to a temperature of 37°C, the MAb was
internalized into intracellular compartments in cells expressing
WT DC-SIGN/L-SIGN but remained at the surface of cells ex-
pressing DEL DC-SIGN/L-SIGN, consistent with major defects in
the endocytic capacity (Fig. 6B, right).
Next, we compared the abilities of pgsA745-DC-SIGN-WT
and pgsA745-DC-SIGN-DEL cells to bind to HMPV in the pres-
ence or absence of Ca2. Representative histograms confirmed
that cell lines expressing WT or DEL DC-SIGN/L-SIGN recog-
nized HMPV in a Ca2-dependent manner (Fig. 6C), consistent
with CLR-mediated recognition of virus. Analysis of the geomet-
ric mean fluorescence intensities from triplicate samples indicated
no significant differences in the abilities of cells expressing WT
and DEL DC-SIGN/L-SIGN to bind HMPV, and all lines showed
significantly enhanced binding in Ca2 compared to pgs-ctrl cells
(data not shown).
Finally, we compared the abilities of HMPV to infect pgsA745
cells expressing WT or endocytosis-defective DEL forms of DC-
SIGN/L-SIGN. We first conducted a standard infection assay,
with the addition of the virus inoculum for 1 h, washing, and
incubation for an additional 17 h before cells were fixed and
stained by immunofluorescence. Surprisingly, we observed that
cells expressing DEL mutants of DC-SIGN/L-SIGN were equally
as susceptible to HMPV infection as cells expressing the appropri-
ate WT receptor (Fig. 6D), and similar results were obtained when
lower doses of the virus inoculum (representing MOIs of 1.5, 0.75,
and 0.25 FFU/cell) were used (data not shown). These findings
imply that following capture by either WT or DEL DC-SIGN/L-
SIGN, the virus is passed to other (unknown) receptors on
pgsA745 cells to promote virus entry.
Next, we modified our standard infection assay such that the
virus inoculum was added for 1 h at 37°C and then washed prior to
the addition of 50 M dynasore to block subsequent endocytic
virus entry during the 17-h culture period (Fig. 6E). As a control,
cells were pretreated with 50 M dynasore, and this was retained
throughout infection and culture. The addition of dynasore after 1
h resulted in a significant reduction of HMPV infection of cells
expressing WT DC-SIGN/L-SIGN; however, this reduction was
more profound in cells expressing DEL DC-SIGN/L-SIGN (Fig.
6E). These studies suggest that cells expressing WT DC-SIGN/L-
SIGN promote infectious entry of HMPV more efficiently during
the first 60 min of infection than cells expressing DEL DC-SIGN/
L-SIGN.
To explore this further, we incubated the virus inoculum with
cells for 60, 30, and 15 min prior to washing and the addition of
dynasore to block subsequent endocytic entry and infection.
FIG 5 DC-SIGN/L-SIGN expression augments HMPV infection of CHO cells
expressing cell surface GAGs. (A) Cell surface expression of DC-SIGN or L-
SIGN on CHO-K1 cells (K1-DC/L-SIGN) or CHO-K1 cells expressing an
irrelevant intracellular protein (K1-ctrl cells) was determined by flow cytom-
etry using a cross-reactive MAb that detects both DC-SIGN and L-SIGN. (B)
Monolayers of K1-ctrl, K1-DC-SIGN, or K1-L-SIGN cells were treated with 50
M dynasore ( dynasore) or mock treated (virus only) for 30 min at 37°C.
Cells were then infected with 3.7 104 FFU (MOI of 0.37 FFU/cell) of HMPV
for 1 h at 37°C, washed, and cultured in serum-free medium alone (virus only)
or supplemented with either 50M dynasore or 20 mM NH4Cl (NH4Cl) for
an additional 17 h. At this time, cells were fixed and stained by immunofluo-
rescence for the expression of viral N. Data represent the mean percentages of
infected cells (1 standard error of the mean) from a minimum of four inde-
pendent fields per chamber and are representative of results from three inde-
pendent experiments. In panel B, * indicates that CHO-K1-DC/L-SIGN cells
are significantly enhanced compared to CHO-K1-ctrl cells (P
 0.01, as deter-
mined by one-way ANOVA followed by Tukey’s post hoc test), and # indicates
that for K1-DC-SIGN and K1-L-SIGN cells, mock treatment is significantly
different from dynasore treatment for each cell line (P
 0.01, as determined
by one-way ANOVA followed by Tukey’s post hoc test).
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FIG 6 pgsA745 cells expressing endocytosis-defective mutants of DC-SIGN/L-SIGN remain susceptible to HPMV infection. (A) Flow cytometry was used to
determine cell surface expression of DC-SIGN (left) or L-SIGN (right) on pgsA745 cells expressing WT or DEL forms of DC-SIGN/L-SIGN. pgsA745-ctrl cells
were included to confirm the specificity of binding. (B) Endocytic capacity of pgsA745 cells expressing different forms of DC-SIGN/L-SIGN following cross-
linking with antibody. Cell monolayers expressing WT or DEL forms of DC-SIGN/L-SIGN were incubated with an anti-DC-SIGN/L-SIGN MAb for 1 h at 4°C,
washed, and incubated for a further 20 min at either 4°C (left) or 37°C (right). Cells were then fixed, stained with Alexa Fluor 488 anti-mouse Ig (green) (to detect
anti-DC-SIGN/L-SIGN MAb) and DAPI (blue) (to stain the nucleus), and examined by confocal microscopy. (C) Binding of HMPV to pgsA745 cells expressing
WT or DEL forms of DC-SIGN/L-SIGN was determined by flow cytometry. Representative histograms of HMPV binding to pgsA745 cells expressing WT or DEL
forms of DC-SIGN/L-SIGN in the presence of 20 mM Ca2 are shown. pgsA745-ctrl cells were included to confirm the specificity of binding. (D) Cells were
incubated with 3 105 FFU (MOI of 3 FFU/cell) of HMPV for 1 h, washed, cultured for an additional 17 h, and then fixed and stained for the expression of the
HMPV N protein. Data show the mean percentages of infection (1 standard deviation). * indicates that values are significantly different from those for
pgsA745-ctrl cells (P
 0.01, as determined by one-way ANOVA followed by Tukey’s post hoc test). No significant differences were observed between pgsA745
cells expressing WT or DEL DC-SIGN and those expressing WT or DEL L-SIGN. (E) To examine endocytic entry during the first 1 h, cells were incubated with
3 105 FFU (MOI of 3 FFU/cell) of HMPV for 1 h and washed, and 50 M dynasore was added during subsequent culture to prevent further endocytosis [
Dyn (60 min)]. As controls, either cells were pretreated with 50M dynasore for 30 min at 37°C and infected with HMPV for 60 min, and dynasore was included
in all washing and culture steps [ Dyn (pretreated)], or cells were infected and incubated with medium alone (untreated). After 18 h, cells were fixed, stained
for the expression of the HMPV N protein, and examined by fluorescence microscopy. Data show the mean percentages of infection (1 standard deviation). *
indicates that values for infected cells treated with dynasore are significantly different from those for cells pretreated with dynasore (P
 0.01, as determined by
one-way ANOVA followed by Tukey’s post hoc test). (F) To gain insight regarding the rate of endocytic entry of HMPV, cells were incubated with 3 105 FFU
(MOI of 3 FFU/cell) of HMPV for either 60, 30, or 15 min and then washed, and 50M dynasore was added to prevent further endocytosis. At 18 h postinfection,
cells were fixed, stained, and examined by fluorescence microscopy. * indicates that infection of DEL cells is significantly reduced compared to that of the
appropriate WT controls (P
 0.01, as determined by two-tailed unpaired Student’s t test).
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Compared to cells expressing WT DC-SIGN/L-SIGN, the addi-
tion of dynasore at 60, 30, or 15 min resulted in significant reduc-
tions in HMPV infection of cells expressing DEL DC-SIGN/L-
SIGN (Fig. 6F). Overall, HMPV infection of cells expressing WT
CLRs was progressively reduced by the shorter incubation periods
prior to the addition of dynasore; however, infection of cells ex-
pressing DEL DC-SIGN/L-SIGN was largely undetectable if dyna-
sore was added after 30 or 15 min of incubation with the virus
inoculum. These experiments confirm that DC-SIGN and L-SIGN
can act as bona fide entry receptors for HMPV, internalizing virus
rapidly to promote infection. Thus, using endocytosis-defective
mutants, different incubation times following HMPV inocula-
tion, and dynasore to block endocytic entry, we demonstrate that
HMPV can enter pgsA745 cells by more than one endocytic route
following the recognition of HMPV by cell surface DC-SIGN/L-
SIGN. In addition to rapid CLR-mediated entry (i.e., increased
infection of cells expressing WT CLRs with shorter incubation
times), CLRs act as attachment factors to promote endocytic entry
by other (unknown) receptors on pgsA745 cells (seen by delayed
infection kinetics in cells expressing DEL mutants).
DISCUSSION
To date, evidence suggests that the attachment and entry of
HMPV into host cells may be a multistep process, involving se-
quential recognition by attachment factors (i.e., GAGs) (17, 20,
21) to localize virus on the cell surface and promote subsequent
interactions with integrins (13–16) and/or other proteinaceous
receptors (17). Moreover, it is possible that these interactions
might also occur within endosomal compartments to promote the
infectious entry of HMPV (15, 23). It should be noted that the
specific HMPV receptor(s) utilized for attachment and infectious
entry may also be cell type specific (e.g., between airway epithelial
cells and immune cells in the lung) and could differ between in
vitro and in vivo settings and between different species. As GAG-
deficient pgsA745 cells did not bind HMPV (Fig. 1C) (17) and
were resistant to HMPV infection (Fig. 1D) (17), this study defines
an experimental system in which GAG-independent interactions
between HMPV and putative cell surface receptors can be inves-
tigated. Moreover, as the infectious entry of HMPV is rescued by
the expression of a single putative receptor in GAG-deficient cells,
these approaches allow characterization of specific receptor-me-
diated HMPV entry pathways and may be exploited in future
studies to determine specific domains and residues within cell
surface receptors that are necessary for the infectious entry of
HMPV.
Recombinant DC-SIGN/L-SIGN (Fig. 2A) and DC-SIGN/L-
SIGN expressed on the surface of GAG-deficient pgsA745 cells
(Fig. 2C and D) recognized HMPV in a Ca2-dependent manner.
Moreover, the expression of DC-SIGN or L-SIGN restored the
capacity of GAG-deficient pgsA745 cells to support HMPV infec-
tion (Fig. 3A). A recent study by Le Nouen et al. highlighted the
relevance of DC-SIGN in enhancing the infectious entry of HMPV
into primary human immune cells, with HMPV infection of
MDDCs being partially blocked in the presence of mannan or an
anti-DC-SIGN MAb (26). Of interest, this pathway was depen-
dent on the presence of HMPV SH and/or G glycoproteins, as
infection by a deletion mutant lacking G and SH was not blocked
by these treatments, suggesting that glycans expressed by HMPV
G/SH, but not the F protein, were the primary ligands for DC-
SIGN. In future studies, it will be of interest to assess appropriate
HMPV deletion mutants in our experimental system to confirm
which viral glycoproteins are recognized by DC-SIGN/L-SIGN to
promote infectious HMPV entry. Moreover, variation in the lo-
cation and number of potential sites of N-linked glycosylation on
HMPV glycoproteins between virus strains is likely to modulate
the efficiency of CLR-mediated recognition, as reported previ-
ously for other viruses such as IAV (reviewed in reference 51). As
the dynamin-independent HMPV entry pathways observed by us-
ing CHO-K1 cells do not operate efficiently in GAG-deficient
pgsA745 cells, CLR-mediated enhancement of HMPV infection
can be studied more effectively in this model.
For many years, paramyxovirus fusion was thought to occur at
the plasma membrane in a pH-independent manner; however,
growing evidence suggests that a number of paramyxoviruses may
enter and infect cells, at least in part, via endocytic pathways. For
example, several studies have implicated endocytic pathways in
the infectious entry of RSV into human cell lines (52–54). Schow-
alter et al. reported that HMPV infection of Vero cells was sensi-
tive to treatment with inhibitors of dynamin or clathrin-mediated
endocytosis (23), and recent studies confirmed that HMPV parti-
cles were internalized into human bronchial epithelial cells via
clathrin-mediated endocytosis in a dynamin-dependent manner
(15). Using GAG-deficient cells that are resistant to HMPV infec-
tion, we demonstrate that the expression of DC-SIGN/L-SIGN
restored permissivity to dynamin-dependent infection, implicat-
ing endocytosis as the sole route of infectious entry under these
conditions. While infection of parental CHO-K1 cells by HMPV
occurred via dynamin-independent pathways, the expression of
DC-SIGN/L-SIGN opened up an alternative dynamin-dependent
pathway of HMPV entry, resulting in enhanced levels of infection
(Fig. 4). These findings confirm that the receptors expressed on
the surface of different cell types are likely to modulate HMPV
entry pathways, and multiple entry pathways may operate simul-
taneously. Consistent with this, the uptake of HMPV by MDDCs
was reported to occur primarily by macropinocytosis, although
DC-SIGN-mediated endocytosis represented an alternative entry
pathway (26). This concept is not limited to HMPV infection. For
example, IAV can enter cells via multiple pathways, including
clathrin-mediated endocytosis, caveolin-mediated endocytosis,
and macropinocytosis (reviewed in reference 55), and the partic-
ular pathway utilized may be influenced by structural features of
the virion (e.g., spherical or filamentous), cell type, experimental
culture conditions, and/or differential expression of cell surface
receptors.
The HMPV F protein contains a conserved RGD motif that
plays a critical role during HMPV infection of human cells by
interacting with RGD-binding integrins at the cell surface to pro-
mote cell-cell fusion and infectious entry (13–16). In addition to
virus binding, RGD-binding integrins are required for a subse-
quent entry step that occurs after fusion but before virus tran-
scription (14), with recent studies implicating their importance
for vesicle trafficking during HMPV entry (15). Previous reports
demonstrated that CHO-K1 cells express high levels of1 integrin
(17) but may also express additional RGD-binding integrins such
as v5, v6, and/or v8 that might also bind HMPV F as well
as other (unknown) proteinaceous receptors (17). By using a
combination of anti-v, anti-5, and anti-1 MAbs to block all
available RGD integrins on human BEAS-2B cells, Cox et al. dem-
onstrated a 90% reduction of HMPV infectivity (14). However,
our experimental system was dependent on the use of pgsA745
C-Type Lectins as Receptors for Metapneumovirus
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cells, a GAG-deficient mutant of the CHO cell line, and we were
unable to identify appropriate MAbs to recognize and block ham-
ster homologues of all RGD integrins. Given that GAG-deficient
cells expressing endocytosis-defective mutants of DC-SIGN/L-
SIGN remained susceptible to HMPV infection using our stan-
dard experimental approaches (Fig. 6D), our data suggest that
these CLRs can act as attachment factors and concentrate the virus
at the cell surface to promote dynamin-dependent entry via alter-
native receptors, possibly RGD binding integrins. HMPV F has
been reported to bind RGD binding integrins in the absence of G,
and HMPV expressing a mutated RGD motif (RAE) in its F pro-
tein was profoundly impaired in its ability to replicate in cell cul-
ture (14). Moreover, HMPV deletion mutants lacking G and SH
did not appear to utilize DC-SIGN-mediated endocytosis to infect
MDDCs (26). Therefore, it would be of interest to compare
HMPV mutants lacking SH/G or with mutations within the RGD
motif of the F protein to gain insights regarding the viral determi-
nants that contribute to CLR-mediated enhancement of HMPV
infection in GAG-deficient cells.
Schowalter et al. reported that syncytium formation promoted
by the HMPV F protein in transfected cells required the exposure
of cells to short pulses of low pH (46), although subsequent studies
demonstrated that this was a rare strain-dependent phenomenon
(45). More recently, Mas et al. implicated four variable residues as
the main determinants of pH-dependent syncytium formation in
HMPV-infected cultures and reported no correlation between the
sensitivity of the F protein to low pH in a syncytium formation
assay and the requirement for a low-pH step to promote virus
entry into cells (47). In our studies, we have focused only on the
infectious entry of HMPV into cells. We report that the dynamin-
dependent entry of CAN97-83 into pgsA745 cells expressing
DC-SIGN/L-SIGN, or into CHO-ctrl cells, was unaffected in the
presence of inhibitors of endosomal acidification (NH4Cl and
Baf-A1), consistent with pH-independent entry. In contrast, both
NH4Cl and Baf-A1 treatments completely blocked pH-dependent
infection of cells by IAV (Fig. 4B/C). It should be noted that
Schowalter et al. reported that NH4Cl or Baf-A1 treatment of
Vero/A549 cells resulted in marked reductions in HMPV infection
by strain CAN97-83 (23), perhaps reflecting differences in cell
types and/or culture conditions or, in particular, virus stocks. In
our hands, CAN97-83 infection of Vero cells was unaffected in the
presence of NH4Cl or Baf-A1 at concentrations that completely
blocked IAV infection of these cells (data not shown).
DC-SIGN and L-SIGN have been implicated in enhancing cel-
lular infection by a range of different viruses, although in many
cases, it is not clear whether enhanced infection results from CLR-
mediated endocytosis or if CLR capture promotes subsequent in-
teractions with other entry receptors (reviewed in reference 25).
However, studies have reported that cells expressing either WT or
endocytosis-defective (DEL) mutants of DC-SIGN/L-SIGN
showed enhanced infection by dengue virus (50) or Ebola virus
(56), highlighting their ability to cooperate with other cellular
receptors to enhance infection. In contrast, while WT DC-SIGN/
L-SIGN enhanced cellular infection by IAV (32) and phlebovi-
ruses (57), endocytosis-defective mutants did not. Here, we dem-
onstrate that the expression of DC-SIGN/L-SIGN by GAG-
deficient cells rescued permissivity to HMPV infection. Moreover,
pgsA745 cells expressing endocytosis-defective mutants of DC-
SIGN/L-SIGN remained susceptible to HMPV infection in our
standard infection assay (inoculum at 37°C for 60 min, wash, and
culture for 18 to 20 h), indicating that they can act as attachment
factors to promote dynamin-dependent HMPV entry via other
(unknown) receptors (Fig. 6D). However, modifying our infec-
tion assays by (i) adding dynasore immediately after 60 min of
incubation with the HMPV inoculum (Fig. 6E) or (ii) reducing
incubation times with the HMPV inoculum to 30 or 15 min prior
to addition of dynasore (Fig. 6F) provided evidence that CLR-
mediated endocytosis can also contribute to HMPV infection.
Thus, in the context of the expression of DC-SIGN/L-SIGN by
GAG-deficient pgsA745 cells, we provide evidence that CLRs can
act as attachment factors and/or as bona fide entry receptors for
HMPV.
Expression of putative receptors in pgsA745 cells removed the
confounding factor of multiple low-affinity interactions between
HMPV and cell surface GAGs. While others have reported the
critical presence of cell surface GAGs for efficient HMPV infection
of Vero cells (17), we found that low-level HMPV infection of
GAG-deficient pgsA745 cells was also inhibited in the presence
of dynasore (Fig. 4A), suggesting that an alternative pathway of
GAG-independent HMPV infection might also operate albeit in-
efficiently. Thus, HMPV entry can occur independently of GAGs
(i.e., pgsA745 cells), although the efficiency of infection was en-
hanced if virions were concentrated at the cell surface by low-
affinity interactions with GAGs (i.e., CHO cells) or by recognition
via DC-SIGN/L-SIGN (i.e., pgsA745-DC/L-SIGN). Of interest,
attachment of HMPV to GAGs (expressed by CHO-K1 cells) or to
DC-SIGN/L-SIGN (expressed by pgsA745 transfectants) pro-
moted dynamin-independent and dynamin-dependent HMPV
infection, respectively. These findings suggest that interactions be-
tween HMPV and different attachment factors (i.e., GAGs on
CHO cells and CLR on pgsA745-DC/L-SIGN cells, respectively)
might modify subsequent pathways of virus entry, possibly by
modulating interactions with particular entry receptors or core-
ceptors. However, while our studies using CHO/pgsA745 cells de-
fine an experimental system to examine putative HMPV receptors
in the presence or absence of GAGs, the relevance of these recep-
tors and pathways to other cellular targets of HMPV infection is
unclear. For example, GAGs have been implicated in the attach-
ment of CAN97-83 to Vero cells (17), yet infection of Vero cells by
CAN97-83 was largely inhibited by dynasore (23), which is in
contrast to our findings that GAG-dependent infection of CHO-
K1 cells by CAN97-83 occurred via dynamin-independent path-
ways (Fig. 4A). Recently, dynamin-dependent HMPV infection of
BEAS-2B airway epithelial cells was also reported (15), confirming
the importance of endocytosis for HMPV entry in other epithelial
cell types. Thus, while we report dynamin-dependent infection of
GAG-deficient pgsA745 cells expressing DC-SIGN/L-SIGN, it is
likely that other endocytic receptors facilitate HMPV infection of
a range of different cell types, including airway epithelial cells. The
specific identity of these receptors and the role of GAGs in mod-
ulating infectious entry into cell types more relevant to HMPV
infection (including airway epithelial cells and macrophages/
DCs) remain to be determined.
Recognition of viruses by DC-SIGN/L-SIGN can result in a
range of outcomes, including modulation of host immunity (e.g.,
DC maturation and migration) and virus uptake for infection
and/or virus dissemination (reviewed in references 58 and 59).
Currently, relatively little is known regarding the consequences of
the recognition of paramyxoviruses by CLRs. DC-SIGN has been
reported to act as an attachment factor for measles virus, thereby
Gillespie et al.
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enhancing CD46/CD150-mediated infection of DCs in cis (60). In
addition, measles virus suppresses RIG-I and Mda5 by activating
DC-SIGN signaling events, resulting in reduced type I interferon
(IFN) responses and enhanced virus replication in DCs (61).
Given that RSV is the human pneumovirus most closely related to
HMPV, it is of interest that DC-SIGN/L-SIGN expression by
pgsA745 cells did not promote RSV infection (Fig. 3C). Consistent
with this, previous studies by Johnson et al. reported that DC-
SIGN/L-SIGN binds the G glycoprotein of RSV; however, the ex-
pression of these CLRs by RSV-resistant K562 and Raji cells, or by
semipermissive NIH 3T3 cells, did not result in increased suscep-
tibility to infection (41). Instead, interactions between the RSV G
glycoprotein and DC-SIGN/L-SIGN were implicated in intracel-
lular signaling and phosphorylation of extracellular signal-regu-
lated kinase 1 (ERK1) and ERK2, which were proposed to limit
DC maturation and cytokine/chemokine production (41). While
DC-SIGN has been implicated as an alternative pathway for
HMPV entry into MDDCs, the functional consequences of this
interaction are not yet fully understood (26). Moreover, as DC-
SIGN is also expressed on alveolar macrophages (62) and L-SIGN
is expressed on endothelial cells, including those in the lungs and
lymph nodes, as well as lung alveolar epithelial cells (63, 64), it will
be of interest to assess the contribution of these and other CLRs in
modulating the responses of different airway cell types to HMPV.
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